Lindsay A MD Rosenwald's Net Worth

$74.6 Million

Estimate Recalculated Sep 8, 2024 07:25PM EST

Who is Lindsay A MD Rosenwald?

Lindsay A MD Rosenwald has an estimated net worth of $74.6 Million. This is based on reported shares across multiple companies, which include ZIOPHARM ONCOLOGY INC, MANHATTAN PHARMACEUTICALS INC, NATIONAL HOLDINGS CORP, CB Pharma Acquisition Corp., Fortress Biotech, Inc., AVENUE THERAPEUTICS, INC., MUSTANG BIO, INC., Checkpoint Therapeutics, Inc., KERYX BIOPHARMACEUTICALS INC, Journey Medical Corp, GENTA INC DE/, INTRAC INC, Innovive Pharmaceuticals, Inc., Cougar Biotechnology, Inc., SITKA SCIENCES, INC., SEWARD SCIENCES, INC., NORTON SOUND ACQUISITION CORP., KODIAK SCIENCES, INC., KANAI SCIENCES, INC., DENALI SCIENCES, INC., CORDOVA SCIENCES, INC., CHITINA SCIENCES, INC., BRISTOL BAY SCIENCES, INC., ARCTIC ACQUISITION CORP., Paramount Acquisition Corp, NOVADEL PHARMA INC, CYPRESS BIOSCIENCE INC, and DOR BIOPHARMA INC.

SEC CIK

Lindsay A MD Rosenwald's CIK is 0000941841

Past Insider Trading and Trends

2005 was Lindsay A MD Rosenwald's most active year for acquiring shares with 82 total transactions. Lindsay A MD Rosenwald's most active month to acquire stocks was the month of December. 2006 was Lindsay A MD Rosenwald's most active year for disposing of shares, totalling 4 transactions. Lindsay A MD Rosenwald's most active month to dispose stocks was the month of May. 2023 saw Lindsay A MD Rosenwald paying a total of $5,378,051.02 for 7,442,937 shares, this is the most they've acquired in one year. In 2009 Lindsay A MD Rosenwald cashed out on 265,538 shares for a total of $9,594,245.33, their largest year based on trade value.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

ZIOPHARM ONCOLOGY INC (TCRT) Snapshot price: $2.83

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
—
0
—
—
0
May 3
Form 3/A
—
0
—
—
0
Form 3
—
0
—
—
0
No matching records found

MANHATTAN PHARMACEUTICALS INC (TGTX) Snapshot price: $22.97

Investor

Lindsay A MD Rosenwald owns 2,564,321 units of Common Stock which is worth $58,902,453.37. From 2003 to 2005 Lindsay A MD Rosenwald acquired a total of 439,800 shares in MANHATTAN PHARMACEUTICALS INC at a cost of $568,967.00.

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4/A
+0.20%
5K
$1.55
$7,750.00
2.56M
Apr 1
Form 4
+0.19%
5K
$1.56
$7,800.00
2.65M
May 11
Form 4
+0.19%
5K
$1.50
$7,500.00
2.64M
May 9
Form 4
+0.19%
5K
$1.40
$7,010.00
2.64M
May 4
Form 4
+0.19%
5K
$1.35
$6,750.00
2.63M
May 3
Form 4
+0.19%
5K
$1.25
$6,250.00
2.63M
Apr 28
Form 4
+0.19%
5K
$1.34
$6,700.00
2.62M
Apr 27
Form 4
+0.19%
5K
$1.46
$7,300.00
2.62M
Apr 26
Form 4
+0.19%
5K
$1.48
$7,400.00
2.61M
Apr 25
Form 4
+0.19%
5K
$1.50
$7,500.00
2.61M
Apr 22
Form 4
+0.19%
5K
$1.53
$7,650.00
2.6M
Apr 21
Form 4
+0.19%
5K
$1.50
$7,500.00
2.6M
Apr 19
Form 4
+0.19%
5K
$1.50
$7,500.00
2.59M
Apr 15
Form 4
+0.19%
5K
$1.57
$7,850.00
2.59M
Apr 14
Form 4
+0.39%
10K
$1.58
$15,800.00
2.58M
Apr 12 - Apr 13
Form 4
+0.19%
5K
$1.60
$8,000.00
2.57M
Apr 8
Form 4/A
+0.20%
5K
$1.55
$7,750.00
2.56M
Apr 1
Form 4
+0.19%
5K
$1.56
$7,800.00
2.57M
Apr 7
Form 4
+0.20%
5K
$1.55
$7,750.00
2.56M
Apr 1
Form 4
+0.07%
1.7K
$1.40
$2,380.00
2.56M
Mar 30
Form 4
+0.20%
5K
$1.46
$7,280.00
2.56M
Mar 29
Form 4
+0.20%
5K
$1.50
$7,500.00
2.55M
Mar 28
Form 4
+0.20%
5K
$1.60
$8,000.00
2.55M
Mar 24
Form 4
+0.02%
500
$1.53
$765.00
2.54M
Mar 22
Form 4
+0.20%
5K
$1.60
$8,000.00
2.54M
Mar 18
Form 4
+0.20%
5K
$1.60
$8,000.00
2.54M
Mar 17
Form 4
+0.20%
5K
$1.70
$8,500.00
2.53M
Mar 8
Form 4
+0.20%
5K
$2.10
$10,500.00
2.53M
Mar 1
Form 4
+0.20%
5K
$1.69
$8,450.00
2.52M
Feb 25
Form 4
+0.20%
5K
$1.51
$7,550.00
2.52M
Feb 18
Form 4
+0.20%
5K
$1.54
$7,700.00
2.51M
Feb 17
Form 4
+0.20%
5K
$1.52
$7,600.00
2.51M
Feb 16
Form 4
+0.20%
5K
$1.55
$7,750.00
2.5M
Feb 14
Form 4
+0.20%
5K
$1.50
$7,500.00
2.5M
Feb 10
Form 4
+0.26%
6.5K
$1.51
$9,815.00
2.49M
Feb 8
Form 4
+0.40%
10K
$1.40
$14,000.00
2.49M
Feb 7
Form 4
+0.41%
10K
$1.38
$13,800.00
2.48M
Feb 4
Form 4
+0.41%
10K
$1.41
$14,100.00
2.47M
Feb 2
Form 4
+0.41%
10K
$1.49
$14,900.00
2.46M
Feb 1
Form 4
+0.41%
10K
$1.40
$14,000.00
2.45M
Jan 31
Form 4
+0.41%
10K
$1.31
$13,100.00
2.44M
Jan 28
Form 4
+0.73%
17.5K
$1.36
$23,725.00
2.43M
Jan 24
Form 4
+0.95%
22.6K
$1.30
$29,392.00
2.41M
Jan 21
Form 4
+1.06%
25K
$1.04
$26,000.00
2.39M
Jan 20
Form 4
+0.43%
10K
$1.06
$10,600.00
2.36M
Jan 19
Form 4
+0.43%
10K
$1.00
$10,000.00
2.35M
Jan 18
Form 4
+0.43%
10K
$1.03
$10,300.00
2.34M
Jan 14
Form 4
+0.43%
10K
$1.03
$10,300.00
2.33M
Jan 13
Form 4
+0.43%
10K
$1.06
$10,600.00
2.32M
Jan 12
Form 4
+1.32%
30K
$1.05
$31,625.00
2.31M
Jan 7 - Jan 10
Form 4
+0.44%
10K
$1.04
$10,400.00
2.28M
Jan 6
Form 4
+0.44%
10K
$0.94
$9,365.00
2.27M
Oct 13 - Oct 14
Form 4
+0.44%
10K
$0.89
$8,900.00
2.26M
Oct 4
Form 4
+0.45%
10K
$0.94
$9,410.00
2.25M
Sep 28
Form 4
+0.95%
21K
$0.84
$17,600.00
2.24M
Aug 17 - Sep 9
Form 3
—
0
—
—
0
No matching records found

NATIONAL HOLDINGS CORP No price found

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 3
—
0
—
—
0
No matching records found

CB Pharma Acquisition Corp. No price found

Co-Chairman and CEO

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
-79.38%
-1.02M
—
—
265K
May 20
Form 4
—
0
—
—
0
Mar 16
Form 4
—
0
—
—
0
Feb 3
Form 4
—
0
—
—
0
Oct 9
Form 4
—
0
—
—
0
Mar 18
Form 4
-7.22%
-100.00K
—
—
1.28M
Jan 5
Form 3
—
0
—
—
0
No matching records found

Fortress Biotech, Inc. (FBIO) Snapshot price: $1.79

President, CEO & Chairman

Lindsay A MD Rosenwald owns 2,893,905 units of Common Stock, par value $0.001 which is worth $5,180,089.95, 2,461,001 units of Common Stock, par value $.001 per share which is worth $4,405,191.79, 40,000 units of SERIES A CUMULATIVE REDEEMABLE PERPETUAL PREFERRED STOCK which is worth $71,600.00, 8,172,897 units of Common Stock which is worth $14,629,485.63 and 127,500 units of SERIES A CUMULATIVE PERPETUAL PREFERRED STOCK which is worth $228,225.00. From 2011 to 2024 Lindsay A MD Rosenwald acquired a total of 14,086,460 shares in Fortress Biotech, Inc. at a cost of $9,169,546.46.

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
+4.08%
5K
$7.48
$37,417.50
127.5K
Jul 11
Form 4
+4.26%
5K
$7.39
$36,971.00
122.5K
Jul 9
Form 4
+4.44%
5K
$7.35
$36,764.50
117.5K
Jul 8
Form 4
+0.70%
20K
$1.64
$32,724.00
2.89M
Jun 28
Form 4
+0.35%
10K
$1.76
$17,589.00
2.87M
May 16
Form 4
+1.78%
50K
$2.38
$118,770.00
2.86M
Jan 5
Form 4
+8.33%
216.47K
—
—
2.81M
Jan 1
Form 4
+152.20%
1.57M
$1.70
$2,664,775.50
2.6M
Nov 14
Form 4
+0.65%
100K
$0.28
$28,330.00
15.45M
Sep 26
Form 4
+21.62%
20K
$10.55
$210,900.00
112.5K
Aug 17 - Aug 18
Form 4
+18.49%
2.4M
$0.84
$1,999,999.52
15.35M
Feb 10
Form 4
+10.43%
1.22M
$0.73
$3,112.72
12.95M
Jun 1 - Jan 1
Form 4
+0.86%
100K
$0.68
$67,960.00
11.73M
Dec 1
Form 4
+0.04%
5K
$0.56
$2,800.00
11.63M
Nov 30
Form 4
+0.87%
100K
$0.70
$69,500.00
11.63M
Oct 21
Form 4
+10.75%
1.12M
$2.36
$6,021.07
11.53M
Jun 1 - Jan 1
Form 4
+11.02%
1.03M
$1.97
$5,632.38
10.41M
Jun 1 - Jan 1
Form 4
+131.25%
52.5K
$18.00
$945,000.00
92.5K
Aug 26
Form 4
+9.38%
804.13K
$1.52
$3,927.08
9.37M
Jun 3 - Jan 1
Form 4
+4.86%
396.82K
$1.26
$499,999.50
8.57M
Jul 18
Form 4
+20.68%
1.4M
—
—
8.17M
Jan 1 - Jan 1
Form 4
∞
40K
$25.00
$1,000,000.00
40K
Nov 6
Form 4
+10.43%
553.43K
$2.03
$1,483.93
5.86M
Dec 1 - Jan 1
Form 4
+0.01%
613
$2.40
$1,471.20
5.3M
Jun 1
Form 4
+10.65%
510.43K
—
—
5.3M
Jan 1
Form 4
+0.01%
586
$2.41
$1,412.26
4.79M
Dec 1
Form 4
+0.02%
785
$1.80
$1,413.00
4.79M
Jun 1
Form 4
+0.02%
974
$1.45
$1,412.30
4.79M
Dec 1
Form 4
+3.23%
150K
$1.61
$241,500.00
4.79M
Nov 6
Form 4/A
+0.08%
2K
$6.95
$13,900.00
2.46M
Jan 23
Form 4
+74.44%
1.98M
—
—
4.64M
Dec 19
Form 4/A
—
0
—
—
0
Oct 25
Form 4
—
0
—
—
0
Feb 7
Form 4
+8.13%
200K
$5.00
$1,000,000.00
2.66M
Jun 22
Form 4
—
0
—
—
0
Feb 10
Form 4/A
+0.08%
2K
$6.95
$13,900.00
2.46M
Jan 22 - Jan 23
Form 4
+0.08%
2K
$6.95
$13,900.00
2.43M
Jan 23
Form 4
+0.08%
2K
$5.66
$11,320.00
2.42M
Jan 20
Form 4
+0.08%
2K
$5.67
$11,340.00
2.42M
Jan 19
Form 4
+0.08%
2K
$5.66
$11,320.00
2.42M
Jan 18
Form 4
+0.08%
2K
$5.40
$10,800.00
2.42M
Jan 17
Form 4
+0.08%
2K
$5.40
$10,800.00
2.42M
Jan 13
Form 4
+0.17%
4K
$5.35
$21,380.00
2.41M
Jan 11 - Jan 12
Form 4
+0.08%
2K
$7.00
$14,000.00
2.41M
Dec 8
Form 4
—
0
—
—
0
Nov 15
Form 3
—
0
—
—
0
No matching records found